SARS-CoV-۲ Omicron: Genotyping, Mutational Analysis, and Characterization of Subvariants in Iran

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 146

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEM-11-2_003

تاریخ نمایه سازی: 7 خرداد 1404

چکیده مقاله:

Background: Several SARS-CoV-۲ variants with distinct characteristics have emerged, with Omicron sub-variants such as BA.۱ to BA.۵ being predominant since late ۲۰۲۱. Distinguishing sub-variants using phylogenetic and molecular analyzes provides a valuable approach in the context of epidemiological research. Materials & Methods: Molecular epidemiology and sub-variants of SARS-CoV-۲ omicron were investigated using ۱۵۰ nasopharyngeal samples from COVID-۱۹ patients in Tehran (Iran) from May ۲۰۲۲ to August ۲۰۲۳. Omicron lineages were differentiated using RT-PCR targeting Q۴۹۳R, L۴۵۲R, and ∆۶۹-۷۰ spike mutations. SARS-CoV-۲ omicron sub-variants were determined by amplicon sequencing. Findings: The mean age of the study participants was ۴۴±۷ years, comprising ۳۸.۶% males and ۶۱.۴% females , which may have an effect on transmission and susceptibility of different ages. Also, ۱۱۷ (۷۸%) samples were positive for one of the three lineages, while ۳۳ (۲۲%) was none of the lineages, which were referred to as conclusive and inconclusive results, respectively. ۶۰.۷% of the samples was the omicron lineage BA.۴ or BA.۵. Conclusion: Considering the prevalence of BA.۴ and BA.۵ in the study population and their differences with the parental SARS-CoV-۲ variant, the primary vaccine seems to be not effective against the current omicron sub-variants. These results underscore the importance of vaccination as a critical strategy to prevent the spread of these variants. The suggested primer sets could be an easy way to screen sample variants and lineages and are useful for screening and sequencing samples in countries with limited resources. Continuous monitoring of omicron sub-variants is recommended for preventing the resurgence of COVID-۱۹.

کلیدواژه ها:

Severe Acute Respiratory Coronavirus ۲ (SARS-CoV-۲) ، Omicron sub-variants ، Genotyping ، Molecular epidemiology

نویسندگان

Mona Roozbehani

Vaccine Research Center, Iran University of Medical Sciences, Tehran

Hossein Keyvani

Department of Virology, School of Medicine, Iran University of Medical Sciences

Alireza Tabibzadeh

Department of Virology, School of Medicine, Iran University of Medical Sciences

Farah Bokharaei Salim

Department of Virology, School of Medicine, Iran University of Medical Sciences

Leila Mousavizadeh

Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Gdoura M, Abouda I, Mrad M, Ben Dhifallah I, Belaiba ...
  • Mousavizadeh L, Soltani R, Abedini K, Ghasemi S. The relation ...
  • Roozbehani M, Keyvani H, Razizadeh M, Yousefi P, Gholami A, ...
  • Singh J, Pandit P, McArthur AG, Banerjee A, Mossman K. ...
  • Duong D. Alpha, beta, delta, gamma: What's important to know ...
  • Roozbehani M, Razizadeh MH, Keyvani H, Nejati F, Soleymani S, ...
  • Leung KS, Shum MH, Leung GM, Lam TT, Wu JT. ...
  • Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, ...
  • Earnest R, Uddin R, Matluk N, Renzette N, Turbett SE, ...
  • Pyke AT, Nair N, van den Hurk AF, Burtonclay P, ...
  • Lupala CS, Ye Y, Chen H, Su XD, Liu H. ...
  • Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. ...
  • Joung SY, Ebinger JE, Sun N, Liu Y, Wu M, ...
  • Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, ...
  • Wang Q, Guo Y, Iketani S, Nair MS, Li Z, ...
  • Colson P, Fournier PE, Delerce J, Million M, Bedotto M, ...
  • Mohapatra RK, Kandi V, Tuli HS, Chakraborty C, Dhama K. ...
  • Zappa M, Verdecchia P, Angeli F. Severe acute respiratory syndrome ...
  • Giancotti R, Lomoio U, Puccio B, Tradigo G, Vizza P, ...
  • Islam MR, Shahriar M, Bhuiyan MA. The latest omicron BA.۴ ...
  • Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, ...
  • Akash S, Islam MR, Dhama K. Emergence BQ.۱ and BQ.۱.۱ ...
  • Philip AM, Ahmed WS, Biswas KH. Reversal of the unique ...
  • Camacho J, Zulaica J, Giménez E, Rusu L, Velandia-Álvarez S, ...
  • Mittal A, Khattri A, Verma V. Structural and antigenic variations ...
  • Vogels CB, Breban MI, Ott IM, Alpert T, Petrone ME, ...
  • Tan CW, Lim BL, Young BE, Yeoh AY, Yung CF, ...
  • Colson P, Gaulret P, Delerce J, Chaudet H, Pontarotti P, ...
  • Hirotsu Y, Maejima M, Shibusawa M, Natori Y, Nagakubo Y, ...
  • Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, ...
  • Zhang Y, Zhang T, Fang Y, Liu J, Ye Q, ...
  • Bin Manjur OH, Afrad MH, Khan MH, Hossain M, Kawser ...
  • Emmelot ME, Vos M, Boer MC, Rots NY, van Els ...
  • Quarleri J, Galvan V, Delpino MV. Omicron variant of the ...
  • Phan T, Boes S, McCullough M, Gribschaw J, Marsh J, ...
  • Yadav PD, Patil DY, Sahay RR, Shete AM, Mohandasa S, ...
  • نمایش کامل مراجع